Literature DB >> 25263461

Hepatotoxicity induced by neonatal exposure to diethylstilbestrol is maintained throughout adulthood via the nuclear receptor SHP.

Aurélie Vega1, Marine Baptissart, Emmanuelle Martinot, Jean-Paul Saru, Silvère Baron, Kristina Schoonjans, David H Volle.   

Abstract

BACKGROUND: Liver physiology is sensitive to estrogens, which suggests that the liver might be a target of estrogenic endocrine disrupters (EED). However, the long-term consequences of neonatal exposure to EED on liver physiology have rarely been studied. The nuclear receptor small heterodimer partner (SHP) mediates the deleterious effects of neonatal exposure to diethylstilbestrol (DES) on male fertility.
OBJECTIVES: As SHP is involved in liver homeostasis, we aimed to determine whether neonatal estrogenic exposure also affected adult liver physiology through SHP. Male mouse pups were exposed to DES in the first 5 days of life.
RESULTS: DES exposure leads to alterations in the postnatal bile acid (BA) synthesis pathway. Neonatal DES-exposure affected adult liver BA metabolism and subsequently triglyceride (TG) homeostasis. The wild-type males neonatally exposed to DES exhibited increased liver weight and altered liver histology in the adult age. The use of deficient male mice revealed that SHP mediates the deleterious effects of DES treatment. These long-term effects of DES were associated with differently timed alterations in the expression of epigenetic factors.
CONCLUSIONS: However, the molecular mechanisms by which neonatal exposure persist to affect the adult liver physiology remain to be defined. In conclusion, we demonstrate that neonatal DES exposure alters adult hepatic physiology in an SHP-dependent manner.

Entities:  

Keywords:  estrogenic endocrine disrupter; liver; small heterodimer partner

Mesh:

Substances:

Year:  2014        PMID: 25263461     DOI: 10.1517/14728222.2014.964209

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  6 in total

1.  Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life.

Authors:  Stephanie Piekos; Chad Pope; Austin Ferrara; Xiao-Bo Zhong
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

Review 2.  Farnesoid X receptor alpha (FXRα) is a critical actor of the development and pathologies of the male reproductive system.

Authors:  Manon Garcia; Laura Thirouard; Mélusine Monrose; Hélène Holota; Angélique De Haze; Françoise Caira; Claude Beaudoin; David H Volle
Journal:  Cell Mol Life Sci       Date:  2019-08-12       Impact factor: 9.261

3.  Bile Acid Alters Male Mouse Fertility in Metabolic Syndrome Context.

Authors:  Aurélie Vega; Emmanuelle Martinot; Marine Baptissart; Angélique De Haze; Frederic Vaz; Wim Kulik; Christelle Damon-Soubeyrand; Silvère Baron; Françoise Caira; David H Volle
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

4.  Bile acid homeostasis controls CAR signaling pathways in mouse testis through FXRalpha.

Authors:  Emmanuelle Martinot; Marine Baptissart; Aurélie Véga; Lauriane Sèdes; Betty Rouaisnel; Fred Vaz; Jean-Paul Saru; Angélique de Haze; Silvère Baron; Françoise Caira; Claude Beaudoin; David H Volle
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

5.  Crosstalk between BPA and FXRα Signaling Pathways Lead to Alterations of Undifferentiated Germ Cell Homeostasis and Male Fertility Disorders.

Authors:  Lauriane Sèdes; Christèle Desdoits-Lethimonier; Betty Rouaisnel; Hélène Holota; Laura Thirouard; Laurianne Lesne; Christelle Damon-Soubeyrand; Emmanuelle Martinot; Jean-Paul Saru; Séverine Mazaud-Guittot; Françoise Caira; Claude Beaudoin; Bernard Jégou; David H Volle
Journal:  Stem Cell Reports       Date:  2018-09-20       Impact factor: 7.765

6.  Multigenerational impacts of bile exposure are mediated by TGR5 signaling pathways.

Authors:  Marine Baptissart; Lauriane Sèdes; Hélène Holota; Laura Thirouard; Emmanuelle Martinot; Angélique de Haze; Betty Rouaisnel; Françoise Caira; Claude Beaudoin; David H Volle
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.